Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Weihao Wang
Hongyan Liu
Shumin Xiao
Shuaihui Liu
Xin Li
Pei Yu
机构：
[1] Tianjin Medical University,Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology
[2] Medical University of Tianjin,Department of Nephrology and Dialysis
来源：
Diabetes Therapy | 2017年 / 8卷
关键词：
Glucagon-like peptide-1 receptor agonists (GLP-1RAs); Insulin; Meta-analysis; Type 1 diabetes (T1DM);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：727 / 738
页数：11
相关论文
共 50 条
  • [1] Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Wang, Weihao
    Liu, Hongyan
    Xiao, Shumin
    Liu, Shuaihui
    Li, Xin
    Yu, Pei
    DIABETES THERAPY, 2017, 8 (04) : 727 - 738
  • [2] Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
    Bruno Geloneze
    José Carlos de Lima-Júnior
    Lício A. Velloso
    Drugs, 2017, 77 : 493 - 503
  • [3] Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review
    Lee, Serene
    Li, Maggie
    Le, Gia Han
    Teopiz, Kayla M.
    Vinberg, Maj
    Ho, Roger
    Au, Hezekiah C. T.
    Wong, Sabrina
    Valentino, Kyle
    Kwan, Angela T. H.
    Rosenblat, Joshua D.
    Mcintyre, Roger S.
    ANNALS OF GENERAL PSYCHIATRY, 2024, 23 (01)
  • [4] Erratum to: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
    Bruno Geloneze
    José Carlos de Lima-Júnior
    Lício A. Velloso
    Drugs, 2017, 77 : 1141 - 1141
  • [5] Glucagon-like peptide-1 receptor agonists as add-on therapy to insulin for type 1 diabetes: a systematic review and meta-analysis
    Rebelos, E.
    Anastasiou, I.
    Tentolouris, N.
    Karagiannis, T.
    Tsapas, A.
    Ferrannini, E.
    Liakos, A.
    DIABETOLOGIA, 2024, 67 : S350 - S351
  • [6] Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain-Adipocyte Axis
    Geloneze, Bruno
    de Lima-Junior, Jose Carlos
    Velloso, Licio A.
    DRUGS, 2017, 77 (05) : 493 - 503
  • [7] Effects of Glucagon-Like Peptide-1 Receptor Agonists on Bone Metabolism in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Li, Xin
    Li, Yang
    Lei, Chen
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2024, 2024
  • [8] Evaluating Cardiovascular Benefits of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) in Type 2 Diabetes Mellitus: A Systematic Review
    Sreenivasan, Chithra
    Parikh, Aneri
    Francis, Aida J.
    Kanthajan, Tatchaya
    Pandey, Manorama
    Alqassab, Osamah
    Nath, Tuheen Sankar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [9] Correlation Study of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) on Diabetic Patients with Hypertension
    Chang, Yeting
    Yu, Qin
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2024, 53 (07) : 1560 - 1568
  • [10] Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: a systematic review
    Au, Hezekiah C. T.
    Zheng, Yang Jing
    Le, Gia Han
    Wong, Sabrina
    Teopiz, Kayla M.
    Kwan, Angela T. H.
    Gill, Hartej
    Badulescu, Sebastian
    Valentino, Kyle
    Rosenblat, Joshua D.
    Mansur, Rodrigo B.
    Mcintyre, Roger S.
    ACTA NEUROPSYCHIATRICA, 2025, 37
12345